As of Dec 08
| -0.26 / -1.65%|
The 8 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 33.00 and a low estimate of 11.50. The median estimate represents a +45.26% increase from the last price of 15.49.
The current consensus among 10 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.